{
  "docId": "019de075-8d44-7401-b489-ee436db9a207",
  "docSlug": "66ec60e76d61a423395d466c32dc56fb",
  "documentTitle": "Exscientia | Investor Presentation Deck | 75 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 73,
  "pageCount": 75,
  "prevPage": 72,
  "nextPage": 74,
  "slideType": "other",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de075-8d44-7401-b489-ee436db9a207/73",
  "deckHref": "/decks/019de075-8d44-7401-b489-ee436db9a207",
  "deckJsonHref": "/decks/019de075-8d44-7401-b489-ee436db9a207.json",
  "deckAnchorHref": "/decks/019de075-8d44-7401-b489-ee436db9a207#slide-73",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.6,
        "x": 0.35,
        "y": 0.27
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c23760e1-c7bc-4f28-9b85-19eb4926bb91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.41,
        "x": 0.086,
        "y": 0.325
      },
      "kind": "list",
      "text": "Pharmacokinetics (PK)\nExcellent PK across preclinical species\nLow predicted human clearance and high oral bioavailability\nHuman clearance data suggests a half-life consistent with QD dosing\nLow DDI risk, differentiating vs other compounds (particularly important in combination with BTKi)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "288c741d-ec30-4712-b70a-7fd1d4e0bfe8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.41,
        "x": 0.523,
        "y": 0.325
      },
      "kind": "list",
      "text": "Toxicology & Safety Pharmacology\nNo unexpected in vitro or in vivo safety concerns identified\nWell tolerated in rat/dog DRF studies\nDose levels in GLP toxicology studies chosen to establish safety margins to predicted human efficacious dose\nGLP-tox and telemetry studies in reporting phase",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da86b9ac-b505-458f-97fc-851f1e6fda28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.68,
        "x": 0.077,
        "y": 0.145
      },
      "kind": "title",
      "text": "Favourable PK, toxicology & safety pharm in preclinical species",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0967ef9d-7a17-44b8-bddf-bf8ca436010d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.175,
        "x": 0.077,
        "y": 0.065
      },
      "kind": "title",
      "text": "MALT1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "198b744f-7810-4787-810c-33d557312b72",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}